Key result
In patients with dilated cardiomyopathy and LVEF <40%, the admission neutrophil-to-lymphocyte ratio was higher in those who died compared to survivors.
Why the study?
The prognostic significance of neutrophil-lymphocyte ratio (NLR) in patients with noncoronarogenic heart failure and reduced LVEF was not established.
Cohort (n=75)
No
Answers are grounded in this paper and cite their sources.
Aim of the study. To determine the prognostic significance of NLR ratio in patients with noncoronarogenic etiology HF during the hospital period and after hospital stay.Materials and methods. Totally, 75 patients were studied. LVEF<40%. The primary endpoint was a lethal outcome. Patients were divided into groups: 1) “dilated cardiomyopathy” (DCM) (n = 51); 2) “myocarditis” (n = 7); 3) “postmyocarditis cardiosclerosis” (n = 10); 4) “other” (n = 7). A general blood test was performed on the day of hospitalization and 7 days later. The long-term prognosis was analyzed according to the data of telephone contacts with patients, their relatives, outpatient cards.Results. A statistically significant relationship was established between NLR on the day of hospitalization and the overall mortality in the group “myocarditis” (NLR (%) = 2.23 + 0.78, p <0.05). NLR of the deceased in the group “DCM” was 3.98 + 0.60, which is significantly higher in comparison with the surviving patients in the same group (NLR 2.28 + 0.17, p<0.001). NLR was significantly decreased in all groups after 7 days (p<0.05 for the “DCM”, and NLR was practically comparable with the data of healthy people in the “PMCC”).Conclusions. The dynamic growth NLR of blood can serve as a predictor of death in patients suffering from DCM with LV EF<40%. NLR should be adopted for stratification of risk in this group of patients.
No takes yet. Share an insight, caveat, or question.
Bakhchoyan et al. (2017) conducted a cohort in Heart failure of noncoronarogenic etiology (n=75). Elevated neutrophil-lymphocyte ratio (NLR) vs. Lower neutrophil-lymphocyte ratio (survivors) was evaluated on Lethal outcome (mortality) in the dilated cardiomyopathy subgroup (p=<0.001). In patients with dilated cardiomyopathy and LVEF <40%, the admission neutrophil-to-lymphocyte ratio was higher in those who died compared to survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: